Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer
Status:
Terminated
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the safety and tolerability of AMG 706 plus
panitumumab when administered with gemcitabine and cisplatin chemotherapy. This is a Phase 1b
clinical study.